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Selective autophagy mediates the degradation of
various cargoes, including protein aggregates and
organelles, thereby contributing to cellular homeo-
stasis. Cargo receptors ensure selectivity by teth-
ering specific cargo to lipidated Atg8 at the isola-
tion membrane. However, little is known about the
structural requirements underlying receptor-medi-
ated cargo recognition. Here, we report structural,
biochemical, and cell biological analysis of the major
selective cargo protein in budding yeast, aminopep-
tidase I (Ape1), and its complex with the receptor
Atg19. The Ape1 propeptide has a trimeric coiled-
coil structure, which tethers dodecameric Ape1
bodies together to form large aggregates. Atg19
disassembles the propeptide trimer and forms
a 2:1 heterotrimer, which not only blankets the
Ape1 aggregates but also regulates their size.
These receptor activities may promote elongation
of the isolation membrane along the aggregate sur-
face, enabling sequestration of the cargo with high
specificity.
INTRODUCTION
Autophagy, an intracellular degradation systemconserved across
most eukaryotes, mediates various physiological processes and
includes selective types of autophagy (Mizushima and Komatsu,
2011). An increasing number of substrates for selective auto-
phagy, termed selective cargoes, have been identified and
include various kinds of biomolecules, organelles, and even
invasive bacteria (Randow and Youle, 2014; Suzuki, 2013).
Saccharomyces cerevisiae aminopeptidase I (Ape1), a vacuolar
enzyme, is one example of a factor that is thought to serve as
selective cargo (Klionsky et al., 1992). Genetic, cell biological,
and biochemical studies on the selective autophagy of Ape1
previously established the concept of receptor-mediated cargoThis is an open access article undselection during selective autophagy (Lynch-Day and Klionsky,
2010).
After translation in the cytoplasm, the precursor form of
Ape1 (prApe1) spontaneously aggregates due to the presence
of its propeptide (Kim et al., 1997). Ape1 aggregates are
promptly and selectively transported to the vacuole through a
specific type of selective autophagy, termed the cytoplasm-
to-vacuole targeting (Cvt) pathway, during growth and through
starvation-induced autophagy, where prApe1 is processed
into a mature form (mApe1) lacking the propeptide by vacu-
olar hydrolases (Klionsky et al., 1992). The Cvt pathway and
starvation-induced autophagy have important differences
relative to each other. First, Cvt pathway-specific autophago-
somes, termed Cvt vesicles, have a much smaller, uniform
size (150 nm) compared with starvation-induced autopha-
gosomes (300–900 nm) (Baba et al., 1994; Noda et al., 2000).
Second, Ape1 aggregates function as a scaffold for membrane
biogenesis, and without them, Cvt vesicles are not formed
(Shintani and Klionsky, 2004). Third, as Cvt vesicle membranes
expand along the surface of Ape1 aggregates, most cyto-
plasmic components are excluded from the Cvt vesicle (Baba
et al., 1997). The latter two features are also observed in se-
lective autophagy of protein crystals (Tsutsui et al., 2015),
peroxisomes, and invasive bacteria (the latter two were named
pexophagy and xenophagy, respectively) (Manjithaya et al.,
2010; Randow and Youle, 2014). In contrast, starvation-induced
autophagosomes do not require cargoes as a scaffold for mem-
brane biogenesis and engulf them together with other various
cytoplasmic components.
Atg19 has been identified as a receptor for Ape1 (Leber et al.,
2001; Scott et al., 2001). Atg19 contains a coiled-coil (CC),
Atg11 binding region and Atg8-family interacting motif (AIM),
and it tethers Ape1 to autophagic membranes through simul-
taneous interactions with Ape1 and lipidated Atg8 via the CC
and AIM regions, respectively (Chang and Huang, 2007; Noda
et al., 2010; Scott et al., 2001; Shintani et al.,2002; Yorimitsu
and Klionsky, 2005). Although the structural basis of the
Atg19AIM-Atg8 interaction has been established (Noda et al.,
2008), structural studies on the Atg19-Ape1 interaction are
lacking.Cell Reports 16, 19–27, June 28, 2016 ª 2016 The Author(s). 19
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Figure 1. Crystal Structure of prApe1
(A) Microscopic observation of prApe1 aggregation in vitro that was caused by removing GST from prApe1. Scale bar, 1 mm.
(B) Size distribution of various Ape1 constructs measured by DLS. d.nm, apparent diameter (nm).
(C) Ribbon representation of the tetrahedral dodecameric architecture of prApe1 L11S. Yellow and dark green indicate two molecules with a 2-fold symmetry.
Orange lines indicate the tetrahedron sides.
(D) Stereo view of the C-terminal portion of the propeptide.
(E) Size distribution of GST-prApe1 C43A with or without treatment with HRV 3C protease measured by DLS.
See also Figure S1.Here, we report the crystal structures of full-length prApe1 and
the propeptide in the self-assembled and Atg19-bound states.
Structural data together with in vitro and in vivo experiments
reveal features of both cargo and receptor, establishing the
structural mechanisms underlying selective autophagy of Ape1.
RESULTS
Crystal Structure of prApe1
In order to establish the structural feature of the scaffolding se-
lective cargo protein, we started a structural study on prApe1.
Purified glutathione S-transferase (GST)-fused prApe1 was
soluble, which immediately formed a large assemblage with a
diameter of 1 mm upon cleavage of GST from prApe1 (Figures20 Cell Reports 16, 19–27, June 28, 20161A and 1B, blue). GST-removed prApe1 was further assembled
into a huge aggregate >100 mm by centrifugation (Figure S1A).
In contrast, mApe1 showed good monodispersity, with a diam-
eter of 15 nm (Figure 1B, red). These observations suggest
that the GST tag inhibited the aggregation of prApe1, and
without the tag, prApe1 spontaneously forms an aggregate de-
pending on the propeptide. The L11S mutation reportedly im-
pairs the formation of the Ape1 complex in vivo (Oda et al.,
1996; Shintani et al., 2002; Suzuki et al., 2002), and we
confirmed that this mutation impaired the formation of prApe1
aggregates in vitro without a GST tag, whose size is similar to
mApe1 (Figure 1B, black). Since wild-type (WT) prApe1 could
not be subjected to crystallization trials due to aggregate forma-
tion, we crystallized and determined the structures of full-length
Ape1 (L11S) and WT mApe1 at a resolution of 2.1 and 1.83 A˚,
respectively (Table S1).
prApe1 formed a tetrahedral dodecamer in the crystal (Fig-
ure 1C), which was almost identical to that of mApe1 determined
here and by another group, except for the propeptide portion
(Figure S1B) (Su et al., 2015). The structure of the propeptide
(residues 1–45) was previously predicted to have a helix-loop-
helix conformation (Martinez et al., 1997; Oda et al., 1996).
Among the 45 residues of the propeptide moiety, only the C-ter-
minal portion (residues 31–45) had defined electron density and
was modeled as an a helix, which corresponds to the second
helix in the prediction (Figure 1C, red ribbons). The propeptide
a helices were placed almost vertically relative to the tetrahedron
enzyme body, although they are not involved in crystal packing
(Figures 1C and S1C). A disulfide bond was formed between
Cys43 of the propeptide and Cys317 of the enzyme body (Fig-
ure 1D). In addition, the side chains of Trp42 and Ile44 in the
propeptide formed extensive interactions with the hydrophobic
residues of the enzyme body. These interactions appeared
to contribute to the vertical configuration of the propeptide.
Dynamic light scattering (DLS) measurement showed that
GST-prApe1 C43A was smaller than GST-prApe1 WT both
before and after protease treatment (Figure 1E). Moreover, a
C43A mutation partially impaired not only the dot formation of
mCherry-prApe1 but also Ape1 maturation in vivo (Figures
S1D–S1G), although the interaction with Atg19 was not affected
(Figure S1H). These data suggest that the enzyme efficiently
forms aggregates by presenting propeptides for self-assembly,
which is important for the Cvt pathway to act efficiently.
Structural Basis of the Propeptide-Mediated Formation
of the Ape1 Complex
The crystal structure of prApe1 L11S did not provide any infor-
mation regarding the N-terminal region of the propeptide, which
mediates the formation of the Ape1 complex (Oda et al., 1996;
Seguı´-Real et al., 1995) and Atg19 interaction (Shintani et al.,
2002; Suzuki et al., 2002). In order to identify the residues in
the propeptide that are directly involved in self-assembly and
in Atg19 binding in solution, we performed nuclear magnetic
resonance (NMR) studies on the N-terminal 45 residues of
Ape1 (Ape1N45). The narrow dispersion of the chemical shifts in
the 1H-15N heteronuclear single quantum coherence (HSQC)
spectrum of 15N-labeled Ape1N45 suggested that Ape1N45 is
largely unstructured at this concentration (25 mM) (Figure S2A).
When the NMR spectrum was measured at a higher concentra-
tion (100 mM), some signals showed a reduction in intensity,
which were clustered at the N-terminal region (residues 1–20)
of the propeptide (Figure S2B). It was shown that the CC-
containing region of Atg19 is responsible for prApe1 binding
(Shintani et al., 2002). We narrowed the binding region for
prApe1 and identified that the CC region (residues 160–187)
of Atg19 (Atg19CC) is sufficient for propeptide binding (see
below). When non-labeled Atg19CC was titrated into 15N-labeled
Ape1N45, the residues with weakened signals were again clus-
tered at the N-terminal region (residues 1–20) of the propeptide
(Figures S2C and S2D). These data clearly suggest that the
N-terminal 20 residues of the propeptide are directly involved
in both self-assembly and Atg19 binding.Accordingly, we crystallized and determined the structure of
Ape1N22 alone and of the Ape1N20-Atg19CC complex at 3.4 and
1.9 A˚ resolution, respectively (Table S1). For crystallization of
Ape1N22, the P22L mutant was used, because we found that
this mutation induces an a-helical conformation of the propep-
tide and enhances self-assembly of propeptides in vitro (Figures
S2E and S2F). The asymmetric unit of the Ape1N22 crystal con-
tained 39 peptide molecules, which could be grouped into 13 tri-
mers (Figures S2G and S2H). Importantly, all of these trimers
consisted of two parallel and one anti-parallel a helices. Previous
ultracentrifugation studies showed that Ape1N45 behaved as
both a monomer (5.7–6.8 kDa) and a trimer (15.4–17.1 kDa) in
the 45–210 mM concentration range (Su et al., 2015), supporting
the idea that Ape1 propeptides form a homotrimer in solution as
in Figure 2A.
The interactions underlying the Ape1N22 P22L homotrimer
were mostly hydrophobic and mainly mediated by Leu8,
Leu11, Leu15, and Leu18 (Figure 2B). In contrast, there were
few hydrophilic and no ionic interactions. These interactions
buried a total surface area of 2,000–2,400 A˚2 of the three proto-
mers. The highly hydrophobic nature of the trimer interface is
consistent with the observation that high salt concentrations
promote prApe1 aggregation (Morales Quinones et al., 2012;
Scott et al., 2001). Moreover, the trimer structure can explain
the severe defect and the enhancement of the Ape1 complex
formation by L11S and P22L mutations (Figure S1D), as both
residues are involved in the hydrophobic interactions construct-
ing the trimer (Figure 2B). Thus, we concluded that the trimeric
interactions of the propeptides are responsible for the formation
of the Ape1 complex.
Structural Basis of prApe1 Recognition by Atg19
In the crystal of the Ape1N20-Atg19CC complex, Atg19CC and
Ape1N20 formed two 2:1 heterotrimers that resemble one other
(Figure S2I). We confirmed using analytical ultracentrifugation
that the 2:1 mixture of Atg19CC and the propeptide behaved as
a 14.1-kDa complex in solution, which is close to the theoretical
value of a 2:1 complex (13.1 kDa) (Figure S2J). Both Atg19CC and
Ape1N20 had a single a-helical conformation, and intriguingly,
they formed a heterotrimer consisting of two parallel a helices
from Atg19CC and one anti-parallel a-helix from Ape1N20 (Fig-
ure 2C), similar to the Ape1N22 homotrimer (Figure 2A). Superim-
position of the Atg19CC-Ape1N20 heterotrimer onto the Ape1N22
homotrimer at the anti-parallel a helix showed that the two
parallel a helices of Atg19CC and Ape1N22 overlapped almost
completely with each other (Figure S2K), strongly suggesting
that the formation of the heterotrimer and homotrimer are mutu-
ally exclusive.
The interaction between Atg19CC and Ape1N20 was mediated
by many hydrophobic and hydrophilic interactions (Figure 2D).
Among these, Ape1N20 Arg5 played an especially important
role, forming salt bridges and hydrogen bonds with Glu171,
Asn175, and Glu178 of Atg19CC. R5Q and L11S mutations in
Ape1N45 severely impaired the Atg19-Ape1N45 interaction
in vitro (Figure 2E), and Ala substitution at Glu171, Asn175, and
Glu178 in Atg19 (3Amutation) abrogated the interaction between
full-length prApe1 and Atg19 both in vitro and in vivo (Figures 2F
and S2L). Moreover, we observed that Ape1 maturation wasCell Reports 16, 19–27, June 28, 2016 21
Figure 2. Structural Basis of Self-Assembly and Atg19 Binding of the Propeptide
(A) Crystal structure of a homotrimer of Ape1N22 P22L. N and C indicate the amino and carboxy termini, respectively.
(B) Stereo view of the interactions observed in the homotrimer of Ape1N22 P22L.
(C) Crystal structure of the Ape1N20-Atg19CC complex.
(D) Stereo view of the interactions observed in the Ape1N20-Atg19CC complex. The broken line represents possible hydrophilic interactions.
(E) In vitro pull-down assay between GST or GST-Ape1N45 variants and Atg19.
(F) In vitro pull-down assay between GST or GST-prApe1 and MBP-Atg19 variants. HRV 3C protease was added in order to separately detect prApe1 and
MBP-Atg19 bands. The bound ratio of prApe1 is shown below the gel image.
(G) Yeast cell lysates fromBY4741derivative strainswere immunoblottedwith anti-Ape1 serum (top), anti-Atg19 antibody (middle), and anti-PGK1 antibody (bottom).
See also Figure S2.
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completely impaired in atg19D cells expressing Atg19 3A (Fig-
ure 2G). These data reveal that in addition to the hydrophobic
interactions, the salt bridges observed in the heterotrimer are
essential for the Atg19-propeptide interaction and for Ape1
maturation. Formation of the heterotrimer buried a total surface
area of 2,800–3,000 A˚2, which is larger than that buried in the
Ape1N22 P22L homotrimer (2,400 A˚2 at the highest among 13 ho-
motrimers). These data suggest that the interaction between
Atg19CC and Ape1N20 is stronger than propeptide self-assembly.
Atg19 Binding Inhibits the prApe1 Aggregation by
Competing with Propeptide Self-Assembly
Structural data suggest that Atg19 would bind competitively
to and inhibit the self-assembly of the propeptide. An in vitro
pull-down assay and DLS showed that the interaction between
GST-Ape1N45 and Ape1N45 was impaired by Atg19CC (Figure 3A)
and that the formation of a large assemblage of prApe1 upon
cleavage of GST (Figures 1A and 1B) was impaired by Atg19CC
(Figure 3B). This inhibitory activity of Atg19CC suggests that
excess amounts of Atg19 would reduce the size of the Ape1
complex in vivo, thus impairing Ape1 maturation. We then fol-
lowed the Ape1 complex using Ape1-mCherry in vivo, finding
that the size of the Ape1 complex was affected by the amount
of Atg19; it was increased in the absence of Atg19 and reduced
under excess Atg19 (Figure 3C), though previous studies indi-
cated that Atg19 overexpression did not affect Ape1 maturation
in vivo (Baxter et al., 2005; Leber et al., 2001). We also performed
similar experiments, which showed that overexpression of Atg19
WT, but not the 3A mutant that is unable to interact with prApe1,
partially impaired Ape1 maturation in cells where endogenous
Atg19 was expressed (Figures 3D and 3E). The discrepancy
with the previous reports might be due to differences in the
expression level of Atg19. This observation suggests that the
excess binding of Atg19 to prApe1 inhibits the Cvt pathway by
reducing the size of prApe1 aggregates.
Atg19 Blankets prApe1 Aggregates In Vivo
It is known that Atg19 binds to the surface of, but is not incorpo-
rated into, the Ape1 complex (Morales Quinones et al., 2012). In
order to observe the localization of Atg19 in the Ape1 complex,
we followed the distribution of Atg19-GFP in cells expressing
excess amounts of prApe1 using the CUP1 promoter, which
leads to the formation of a giant Ape1 aggregate >1 mm in vivo
(Suzuki et al., 2013). Atg19-GFP expressed from the endogenous
promoter localized mainly to the surface of the giant Ape1 com-
plexes, but not evenly (Figure 3F), possibly because the amount
of Atg19 was insufficient for evenly blanketing these giant com-
plexes. GFP-Atg19 was then overexpressed, and two types of
prApe1 were also expressed: tag-free prApe1 was overex-
pressed in order to make a giant Ape1 complex, and RFP-Ape1
was expressed using the endogenous promoter in order to label
the giant Ape1 complex. As expected, Atg19-GFP signals clearly
and evenly blanketed the giant Ape1 complex (Figure 3G). In
addition, GFP-Atg19 rings were sometimes observed inside the
giant Ape1 complexes, and importantly, these rings did not
contain RFP-Ape1 signals (Figures 3G and S3). We speculate
that after blanketing most of the giant Ape1 complex, excess
Atg19 deformed the surface of the complex, resulting in theformation of GFP-Atg19 rings. It should be noted that the size
of the Ape1 complex containing Atg19 rings is significantly larger
than that without Atg19 rings (Figure S3), suggesting that in cells
expressing the endogenous level of Ape1, Atg19 localizes to the
surface of the Ape1 complex. These data strongly suggested that
Atg19 has the ability to blanket the Ape1 complex.
Atg19 Regulates the Size of the Ape1 Complex Optimal
as a Selective Cargo
It is known that the diameter of Cvt vesicles is consistently
150 nm, which contrasts with the various sizes (300–900 nm)
of starvation-induced autophagosomes (Baba et al., 1994;
Noda et al., 2000). In order to reveal whether the size of prApe1
is important for the Cvt pathway, we tried to change the size of
prApe1 aggregates without affecting Atg19 association. Since
mutations that destroy propeptide self-assembly also impair
Atg19 interaction, we designed a prApe1 mutant by fusing
prApe1 to the Atg-protein-recruiting region (ARR; residues
363–415) of Atg19 that contains both Atg8 and Atg11 binding
sites (prApe1-Atg19ARR) (Figure 4A). In atg19D ape1D cells ex-
pressing prApe1-Atg19ARR, efficient maturation of prApe1-
Atg19ARR was observed under rapamycin treatment conditions
(Figure 4B, rapamycin 2 hr), suggesting that the Atg19ARRmoiety
fused to prApe1 can, at least partially, complement the function
of Atg19. However, this fusion protein was not delivered to the
vacuole under growing conditions, suggesting that it could not
behave as a scaffold for the Cvt pathway (Figure 4B, Growing).
Since prApe1-Atg19ARR lacks Atg19CC that negatively regulates
the size of prApe1 in vitro (Figure 3B), we speculated that the
fusion protein became too large to be a target for the Cvt
pathway. When Atg19CC-GFP was co-expressed using the
endogenous Atg19 promoter, maturation of prApe1-Atg19ARR
was observed even under growing conditions (Figure 4C, top).
In these cells, free GFP was also observed (Figure 4C, top mid-
dle), implying that Atg19CC-GFP bound to prApe1-Atg19ARR was
delivered to the vacuole through the Cvt pathway. The ability of
prApe1-Atg19ARR to bind Atg19CC was confirmed by in vitro pull-
down assay (Figure S4). Fluorescence microscopy also showed
that prApe1-mCherry-Atg19ARR was delivered to the vacuole
when GFP-Atg19CC was co-expressed but was rarely delivered
without GFP-Atg19CC co-expression (Figure 4D). A markedly
bright dot of prApe1-mCherry-Atg19ARR was frequently
observed only in cells not expressing GFP-Atg19CC (Figure 4D),
suggesting that without Atg19CC, prApe1-mCherry-Atg19ARR
cannot act as a cargo for the Cvt pathway, perhaps due to its
size. Taken together, these data suggest that Atg19CC binding
to the propeptide of prApe1-Atg19ARR regulates the size of this
fusion protein, which enables it to function as a scaffold or a
template for membrane biogenesis in the Cvt pathway.
DISCUSSION
Crystallographic studies showed that 12 copies of a propeptide
protrude in a vertical manner from the tetrahedral dodecameric
architecture of Ape1, and this involves a disulfide bond between
the propeptide and enzyme body (Figures 1C and 1D), while
isolated propeptides form a homotrimeric CC architecture with
two parallel and one anti-parallel a helices (Figure 2A). TheseCell Reports 16, 19–27, June 28, 2016 23
Figure 3. Atg19 Blankets the Ape1 Complex by Competing with Propeptide Self-Assembly
(A) In vitro pull-down assay between GST-Ape1N45 and Ape1N45 in the presence of 0, 10, 30, or 50 mg Atg19CC (156–187).
(B) Size distribution of GST-prApe1 under the existence of Atg19CC with or without protease treatment measured by DLS.
(C) Fluorescence microscopy to observe dot formation of Ape1-mCherry in atg1D atg19D (top) and atg1D (middle, bottom) cells expressing Atg19 under CUP1
promoter (bottom). Scale bar, 5 mm.
(D) Lysates from BY4741 derivative strains expressing WT Atg19 and Atg19 3A under the CUP1 promoter were immunoblotted with anti-Ape1 serum (top), anti-
Atg19 antibody (top middle, short exposure; bottom middle, long exposure), and anti-PGK1 antibody (bottom).
(E) prApe1 and mApe1 bands in (D) were quantified and the average ratio of mApe1 and prApe1 obtained from three independent experiments are shown. **p <
0.005; error bars represent SD from three independent experiments.
(legend continued on next page)
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Figure 4. Atg19CC Regulates the Size of prApe1 Aggregates Optimal for the Cvt Pathway
(A) Schematic diagram of prApe1-Atg19ARR chimeric protein.
(B) BY4741 derivative strains with or without prApe1-Atg19ARR expression were collected from a growing condition or after rapamycin treatment for 2 hr. The cell
lysates were immunoblotted with anti-Ape1 serum (top), anti-Atg19 antibody (middle), and anti-PGK1 antibody (bottom).
(C) BY4741 derivative strains with or without prApe1-Atg19ARR and/or GFP-Atg19CC expression were collected from a growing condition. The lysates were
immunoblotted with anti-Ape1 serum (top), anti-GFP antibody (top middle), anti-Atg19 antibody (bottom middle), and anti-PGK1 antibody (bottom).
(D) Observation of prApe1-mCherry-Atg19ARR with or without co-expression of GFP-Atg19CC. V indicates vacuole. Scale bars, 1 mm.
(E) Proposed model of the Ape1 complex and its sequestration by an isolation membrane during the Cvt pathway.
See also Figure S4.structures suggest that prApe1 dodecamers are connected to
one another through formation of a propeptide trimer, two from
one dodecamer and one from another, which leads to the forma-
tion of prApe1 aggregates, named the Ape1 complex (Figure 4E).
The structure of the Atg19CC-Ape1N20 complex showed strik-
ing similarity to the propeptide trimer, consisting of two parallel a
helices from Atg19CC and one anti-parallel a helix from Ape1N20(F) Fluorescence microscopy to observe Atg19-GFP expressed at a natural level
for 5 hr (bottom). Scale bar, 1 mm.
(G) Fluorescence microscopy to observe overexpressed GFP-Atg19 in cells overe
after treatment with rapamycin for 3 hr (bottom). Scale bar, 5 mm.
See also Figure S3.(Figure 2C), explaining the mutual exclusivity between propep-
tide self-assembly and Atg19 binding observed in vitro (Fig-
ure 3A). We argue that through binding competition, Atg19 nega-
tively regulates prApe1 aggregation both in vitro and in vivo
(Figures 3B and 3C). Importantly, the prApe1-Atg19ARR fusion
protein expressed in atg19D ape1D cells was delivered into the
vacuole only when Atg19CC-GFP was co-expressed (Figuresin cells overexpressing prApe1 before (top) and after treatment with rapamycin
xpressing prApe1 and expressing RFP-Ape1 at a natural level before (top) and
Cell Reports 16, 19–27, June 28, 2016 25
4C and 4D). These observations establish an important role for
Atg19 in the Cvt pathway other than specific recognition of
prApe1, that is, regulating the size of prApe1 aggregates so
they are optimal for transport into the vacuole.
Since Atg19-bound propeptides lose their ability to self-
assemble, prApe1 aggregates cannot grow in the direction
where Atg19 is bound. As a result, growth of prApe1 aggregates
stops when they are surrounded by Atg19. On the basis of this
mechanism, most Atg19 molecules eventually bind to the sur-
face of the Ape1 complex, while little is incorporated inside it
(Figure 3G). The ability of Atg19 to blanket the Ape1 complex
and to bind Atg8-PE using AIM (Noda et al., 2008; Shintani
et al., 2002) and additional binding sites at the ARR (Sawa-Ma-
karska et al., 2014) would enable the isolation membrane to
expand along the surface of the Ape1 complex while excluding
most cytoplasmic components under growing conditions (Fig-
ure 4E). Thus, Atg19 possesses the sophisticated ability to func-
tion as a receptor for selective autophagy that excludes most of
the cytoplasmic components other than the specific cargo.
EXPERIMENTAL PROCEDURES
X-Ray Crystallography
All recombinant proteins were expressed usingEscherichia coliBL21. Purifica-
tion was performed by affinity chromatography and size exclusion chromatog-
raphy. Crystallization was performed by the sitting-drop vapor diffusion
method at 20C. Diffraction data were collected at beamlines NE3A and
NW12A at KEK, Japan, or at beamline BL41XU at SPring-8, Japan. Structure
determination was performed by single anomalous dispersion method for the
Ape1N20-Atg19CC complex, by single isomorphous replacement with anoma-
lous scattering for Ape1N22 P22L, and by the molecular replacement method
for mApe1 and prApe1 L11S. Further detailed procedures are described in
Supplemental Experimental Procedures.
Functional Analyses
NMR spectra were obtained at 25C on Varian Unity Inova 600 spectrometers.
DLSwasmeasured at 25C using Zetasizer nano S (Malvern). CD spectra were
measured at 20C using a J-720W spectropolarimeter (Jasco). Analytical
ultracentrifugation was performed at 20C using Optima XL-I (Beckman
Coulter). Pull-down assays were performed using glutathione Sepharose 4B
(GE Healthcare), GST-accept (Nakacali Tesque), or Amylose resins (New
England Biolabs). Yeast experiments were performed using the stains listed
in Table S2. Further detailed procedures are described in Supplemental Exper-
imental Procedures.
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